SURGICAL IMPLANTS ARTERIAL

Brand Owner Address Description
PARIETENE SOFRADIM PRODUCTION 116 Avenue du Formans Trevoux F-016 France SURGICAL IMPLANTS [ AND ARTERIAL PATCHES ] MADE OF LIVING MATERIALS; IMPLANTS, NAMELY, [ GANGLION IMPLANTS, ] GYNECOLOGIC IMPLANTS [, VASCULAR IMPLANTS, NEUROLOGIC IMPLANTS AND ORTHOPEDIC IMPLANTS ALL ] COMPRISING LIVING TISSUE;IMPLANTS, namely, [ BONE IMPLANTS; ] SURGICAL IMPLANTS AND [ GANGLION IMPLANTS, ] GYNECOLOGIC IMPLANTS, [ VASCULAR IMPLANTS, NEUROLOGIC IMPLANTS, AND ORTHOPEDIC IMPLANTS, ] ALL COMPRISING ARTIFICIAL MATERIALS; PROSTHESES, NAMELY, [ BONE PROSTHESES, GANGLION PROSTHESES, VASCULAR PROSTHESIS, ] GYNECOLOGIC PROSTHESES, [ NEUROLOGIC PROSTHESES, ORTHOPEDIC PROSTHESES, ] AND PROSTHESES FOR ALL BODY PARTS, NAMELY, ABDOMINAL WALL, URINARY BLADDERS, VAGINAS, UTERUSES, RECTUMS, [ INTESTINES, STOMACHS, THORACIC WALLS, PERICARDIUMS, KNEE LIGAMENTS AND TENDONS, SHOULDER LIGAMENTS AND TENDONS, FOOT TENDONS, HAND TENDONS, ARTERIAL WALLS, AND DURA MATER; ] PARIETAL, VISCERAL, [ AND VASCULAR ] PROSTHESES; [ PROSTHETIC LIGAMENTS; ] PROSTHETIC TISSUES FOR PARIETAL[, ] * AND * VISCERAL [ AND VASCULAR ] USE; AND ALL PRODUCTS MADE FROM THESE TISSUES, NAMELY, SURGICAL MESHES, SURGICAL PATCHES, PROSTHETIC LIGAMENTS [, PROSTHETIC TENDONS, TENDON AND LIGAMENT REINFORCEMENTS, ARTERIAL PATCHES, ARTERIAL PROSTHESES, ENDOVASCULAR PROSTHESIS, AND ENDOVASCULAR STENTS ];
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A system for implanting a surgical device to control the circumference of internal anatomic passages corrects physiologic dysfunctions resulting from a structural lumen which is either too large or too small. Implants are disclosed which employ various means for adjusting and maintaining the size of an orifice to which they are attached. Systems permit the implants to be implanted using minimally invasive procedures and permit final adjustments to the circumference of the implants after the resumption of normal flow of anatomic fluids in situ. Methods are disclosed for using the implants to treat heart valve abnormalities, gastroesophageal abnormalities, anal incontinence, and the like.